Volume 9, Issue 2
Editorialp. 103
Joint hypermobility syndrome/ Ehlers�Danlos syndrome hypermobility type: constructing a rehabilitative approach
Author(s): C Celletti, M Castori, G Morico & F Camerota
News and Viewsp. 107
Otezla (apremilast) approved for the treatment of adults with active psoriatic arthritis
Author(s): News
News and Viewsp. 107
Rheumatoid arthritis patients at increased risk of developing kidney disease
Author(s): News
News and Viewsp. 107
Predicting response: new study offers insight into which osteoarthritis patients will respond to NSAIDs
Author(s): News
News and Viewsp. 107
Managing osteoarthritis pain: brain wave study suggests talking-therapy treatments may be the way forward
Author(s): News
Case Reportp. 115
Behcet�s disease, chronic myelomonocytic leukemia and trisomy 8
Author(s): Carolina Munoz-Grajales, Franchezca Zapata Gonzalez, Roberto Benavides Arenas, Carlos Jaime Velasquez Franco, Carolina Echeverri, Javier Dario Marquez Hernandez, Kenny Mauricio Galvez Cardenas and Luis Fernando Pinto Penaranda
Conceptual Paperp. 121
The potential role of blisibimod for the treatment of systemic lupus erythematosus
Author(s): MA Scheinberg, D Srinivasan & RS Martin
Perspective Articlep. 135
The future of treatment for juvenile idiopathic arthritis
Author(s): K Nanda & CA Wallace
Review Articlep. 147
Aiming for remission in psoriatic arthritis
Author(s): AR Moverley, LC Coates & PS Helliwell
Review Articlep. 155
Are cellular mechanosensors potential therapeutic targets in osteoarthritis?
Author(s): S Drexler, A Wann & TL Vincent
Review Articlep. 169
Diet and rheumatoid arthritis development: what does the evidence say?
Author(s): D Di Giuseppe & A Wolk
Review Articlep. 183
Potential of stem cells in the treatment of rheumatic disease
Author(s): R Giacomelli, P Ruscitti, P Di Benedetto, V Liakouli, F Carubbi & P Cipriani
Review Articlep. 197
Future directions for the management of pain in osteoarthritis
Author(s): N Sofat & A Kuttapitiya
Review Articlep. 217
Overview of the pathogenesis, diagnosis and treatment of Dupuytren�s disease
Author(s): DR Mandel & PJ DeMarco
